[HTML][HTML] Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
T Greenstein, BB Aldridge - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
T Greenstein, B Aldridge - Frontiers in Cellular and Infection …, 2022 - europepmc.org
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
T Greenstein, BB Aldridge - Frontiers in cellular and …, 2023 - pubmed.ncbi.nlm.nih.gov
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
T Greenstein, BB Aldridge - 2023 - agris.fao.org
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
[HTML][HTML] Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
T Greenstein, BB Aldridge - Frontiers in Cellular and Infection …, 2022 - ncbi.nlm.nih.gov
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis.
T Greenstein, BB Aldridge - Frontiers in Cellular and Infection …, 2022 - europepmc.org
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …